Bobrowski AE, Langman CB (2006) Hyperoxaluria and systemic oxalosis: current therapy and future directions. Expert Opin Pharmacother 7:1887–1896. https://doi.org/10.1517/14656566.7.14.1887

Article  CAS  Google Scholar 

Hoppe B, Beck BB, Milliner DS (2009) The primary hyperoxalurias. Kidney Int 75:1264–1271. https://doi.org/10.1038/ki.2009.32

Article  CAS  Google Scholar 

Hoppe B (2012) An update on primary hyperoxaluria. Nat Rev Nephrol 8:467–475. https://doi.org/10.1038/nrneph.2012.113

Article  CAS  Google Scholar 

Pey AL, Albert A, Salido E (2013) Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I. Biomed Res Int 2013:687658. https://doi.org/10.1155/2013/687658

Article  CAS  Google Scholar 

van Woerden CS, Groothoff JW, Wanders RJA, Davin JC, Wijburg FA (2003) Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 18:273–279. https://doi.org/10.1093/ndt/18.2.273

Article  Google Scholar 

Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, Lieske JC, Milliner DM, Harris PC (2015) Phenotype-Genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol 26:2559–2570. https://doi.org/10.1681/ASN.2014070698

Article  CAS  Google Scholar 

Danpure CJ (1968) Peroxisomal alanine:glyoxylate aminotransferase and prenatal diagnosis of primary hyperoxaluria type 1. Lancet 2:1168. https://doi.org/10.1016/s0140-6736(86)90584-2

Article  Google Scholar 

Cochat P, Liutkus A, Fargue S, Basmaison O, Ranchin B, Rolland MO (2006) Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol 21:1075–1081. https://doi.org/10.1007/s00467-006-0124-4

Article  Google Scholar 

Knauf F, Asplin JR, Granja I, Schmidt IM, Moeckel GW, David RJ, Flavell RA, Aronson PS (2013) NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int 84:895–901. https://doi.org/10.1038/ki.2013.207

Article  CAS  Google Scholar 

Hoppe B, Kemper MJ, Bokenkamp A, Langman CB (1998) Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int 54:921–925. https://doi.org/10.1046/j.1523-1755.1998.00066.x

Article  CAS  Google Scholar 

Behnke B, Kemper MJ, Kruse HP, Müller-Wiefel DE (2001) Bone mineral density in children with primary hyperoxaluria type I. Nephrol Dial Transplant 16:2236–2239. https://doi.org/10.1093/ndt/16.11.2236

Article  CAS  Google Scholar 

Cochat P, Basmaison O (2000) Current approaches to the management of primary hyperoxaluria. Arch Dis Child 82:470–473. https://doi.org/10.1136/adc.82.6.470

Article  CAS  Google Scholar 

Bacchetta J, Boivin G, Cochat P (2016) Bone impairment in primary hyperoxaluria: a review. Pediatr Nephrol 31:1–6. https://doi.org/10.1007/s00467-015-3048-z

Article  Google Scholar 

Schnitzler CM, Kok JA, Jacobs DW, Thomson PD, Milne FJ, Mesquita JM, King PC, Fabian VA (1991) Skeletal manifestations of primary oxalosis. Pediatr Nephrol 5:193–199. https://doi.org/10.1007/BF01095951

Article  CAS  Google Scholar 

Lorenzo V, Alvarez A, Torres A, Torregrosa V, Hernández D, Salido E (2006) Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience. Kidney Int 70:1115–1119. https://doi.org/10.1038/sj.ki.5001758

Article  CAS  Google Scholar 

Hernandez JD, Wesseling K, Pereira R, Gales B, Harrison R, Salusky IB (2008) Technical approach to iliac crest biopsy. Clin J Am Soc Nephrol 3(Suppl 3):S164-169. https://doi.org/10.2215/CJN.00460107

Article  Google Scholar 

Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschênes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC; ILLUMINATE-A Collaborators  (2021) Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N Engl J Med 384:1216–1226. https://doi.org/10.1056/NEJMoa2021712

Article  CAS  Google Scholar 

Hoppe B, Koch A, Cochat P, Garrelfs SF, Baum MA, Groothoff JW, Lipkin G, Coenen M, Schalk G, Amrite A, McDougall D, Barrios K, Langman CB (2022) Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria. Kidney Int 101:626–634. https://doi.org/10.1016/j.kint.2021.08.015

Article  CAS  Google Scholar 

Danpure CJ (2004) Molecular aetiology of primary hyperoxaluria type 1. Nephron Exp Nephrol 98:e39-44. https://doi.org/10.1159/000080254

Article  CAS  Google Scholar 

Williams EL, Acquaviva C, Amoroso A, Chevalier F, Coulter-Mackie M, Monico CG, Giachino D, Owen T, Robbiano A, Salido E, Waterham H, Rumsby G (2009) Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum Mutat 30:910–917. https://doi.org/10.1002/humu.21021

Article  CAS  Google Scholar 

Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637. https://doi.org/10.1681/ASN.2008030287

Article  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006

Article  Google Scholar 

KDIGO (2013) KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:5–14

Google Scholar 

Hoppe B, Kemper MJ, Bökenkamp A, Portale AA, Cohn RA, Langman CB (1999) Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 56:268–274. https://doi.org/10.1046/j.1523-1755.1999.00546.x

Article  CAS  Google Scholar 

Vallières M, Freeman CR, Skamene SR, El Naqa I (2015) A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys Med Biol 60:5471–5496. https://doi.org/10.1088/0031-9155/60/14/5471

Article  Google Scholar 

Strauss SB, Waltuch T, Bivin W, Kaskel F, Levin TL (2017) Primary hyperoxaluria: spectrum of clinical imaging findings. Pediatr Radiol 47:96–103. https://doi.org/10.1007/s00247-016-3723-7

Article  Google Scholar 

Wiggelinkhuizen J, Fisher RM (1982) Oxalosis of bone. Pediatr Radiol 12:307–309. https://doi.org/10.1007/BF00973200

Article  CAS  Google Scholar 

Brancaccio D, Poggi A, Ciccarelli C, Bellini F, Galmozzi C, Poletti I, Maggiore (1981) Bone changes in end-stage oxalosis. AJR Am J Roentgenol 136:935–939. https://doi.org/10.2214/ajr.136.5.935

Article  CAS  Google Scholar 

El Hage S, Ghanem I, Baradhi A, Mourani C, Mallat S, Dagher F, Kharrat K (2008) Skeletal features of primary hyperoxaluria type 1, revisited. J Child Orthop 2:205–210. https://doi.org/10.1007/s11832-008-0082-4

Article  Google Scholar 

Devresse A, Lhommel R, Godefroid N, Goffin E, Kanaan N (2022) 18-Fluorodeoxyglucose positron emission computed tomography for systemic oxalosis in primary hyperoxaluria type 1. Am J Transplant 22:1001–1002. https://doi.org/10.1111/ajt.16887

Article  CAS  Google Scholar 

Tonnelet D, Benali K, Rasmussen C, Goulenok T, Piekarski E (2020) Diffuse hypermetabolic bone marrow infiltration in severe primary hyperoxaluria on FDG PET. Clin Nucl Med 45:e296–e298. https://doi.org/10.1097/RLU.0000000000003047

Article  Google Scholar 

Kwon HW, Kim JP, Lee HJ, Paeng JC, Lee JS, Cheon GJ, Lee DS, Chung JK, Kang KW (2016) Radiation dose from whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography: nationwide survey in Korea. J Korean Med Sci 31(Suppl 1):S69-74. https://doi.org/10.3346/jkms.2016.31.S1.S69

Article  CAS  Google Scholar 

Lagies R, Udink Ten Cate FEA, Feldkötter M, Beck BB, Sreeram N, Hoppe B, Herberg U (2019) Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study. Pediatr Nephrol 34:2591–2600. https://doi.org/10.1007/s00467-019-04330-7

Article  Google Scholar 

Van Der Hoeven SM, Van Woerden CS, Groothoff JW (2012) Primary hyperoxaluria Type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort. Nephrol Dial Transplant 27:3855–3862. https://doi.org/10.1093/ndt/gfs320

Article  CAS  Google Scholar